Literature DB >> 11498260

Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination.

L Zheng1, M A Calenoff, M C Dal Canto.   

Abstract

The BeAn strain of Theiler's murine encephalomyelitis virus (TMEV) persists in the CNS and produces a chronic inflammatory demyelinating disease that is an animal model for human multiple sclerosis (MS). The mechanisms leading to TMEV-induced demyelination are still under study but most likely involve both immune-mediated and virus induced damage to cells in the CNS, both depending on viral persistence. It is therefore important to identify the cells in which continued virus production is permitted. In this study, we looked at virus infection in primary astrocytes, microglia and oligodendrocytes, derived from brains of neonatal susceptible SJL/J mice. As evidenced by Western blots and immunocytochemistry, we were able to detect viral antigens in all these brain-derived cells. In addition, we extended the study to spinal cord tissues from mice suffering TMEV-induced disease. Immunohistochemistry staining with anti-TMEV sera and antibodies to specific cell markers detected viral antigens in all these cells. We then asked the question whether viral antigen present in these cells, particularly in microglia/macrophages, represented true viral replication or not. By using different techniques, including immunoprecipitation experiments and the very sensitive method of negative RNA detection through RNase protection assay, we show that both astrocytes and oligodendroglia permit de novo viral replication and viral protein synthesis but with only minimal cytopathic effects. Of these two cell types, astrocytes carry the brunt of viral replication. In microglia, on the other hand, viral replication is restricted since only minimal amounts of negative RNA copies can be demonstrated, while there are clear signs that some of these cells undergo apoptosis. These findings show that the main cell for viral replication is the astrocyte, rather than the microglia/macrophage. Most of the viral antigen present in macrophages, therefore, is probably the result of phagocytosis, rather than actual viral replication. In view of the demonstrated presence of viral replication in astrocytes and of great amounts of viral antigens in microglia/macrophages, it is possible that both types of cells act as antigen presenting cells during this immunopathological disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498260     DOI: 10.1016/s0165-5728(01)00338-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  28 in total

1.  Epitope-tagged L* protein of Theiler's murine encephalomyelitis virus is expressed in the central nervous system in the acute phase of infection.

Authors:  Kunihiko Asakura; Harunobu Murayama; Toshiki Himeda; Yoshiro Ohara
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappaB activation: potential role for the initiation of demyelinating disease.

Authors:  JoAnn P Palma; Daeho Kwon; Neil A Clipstone; Byung S Kim
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Non-AUG-initiated internal translation of the L* protein of Theiler's virus and importance of this protein for viral persistence.

Authors:  Olivier van Eyll; Thomas Michiels
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Anti-CCL2 treatment inhibits Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  William J Karpus; Kevin J Kennedy; Brian T Fife; Jamie L Bennett; Mauro C Dal Canto; Steven L Kunkel; Nicholas W Lukacs
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

5.  Chronic social stress impairs virus specific adaptive immunity during acute Theiler's virus infection.

Authors:  Erin E Young; Elisabeth G Vichaya; Nicole M Reusser; Jennifer L Cook; Andrew J Steelman; C Jane R Welsh; Mary W Meagher
Journal:  J Neuroimmunol       Date:  2012-09-27       Impact factor: 3.478

6.  Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease.

Authors:  Mark Trottier; Brian P Schlitt; Aisha Y Kung; Howard L Lipton
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Pro-inflammatory functions of astrocytes correlate with viral clearance and strain-dependent protection from TMEV-induced demyelinating disease.

Authors:  Pamela A Carpentier; Meghann Teague Getts; Stephen D Miller
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

8.  Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus.

Authors:  Paul T Massa; Stacie L Ropka; Sucharita Saha; Karen L Fecenko; Kathryn L Beuler
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Theiler's virus infection induces a predominant pathogenic CD4+ T cell response to RNA polymerase in susceptible SJL/J mice.

Authors:  Young-Hee Jin; Bongsu Kang; Byung S Kim
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

10.  Restraint stress modulates virus specific adaptive immunity during acute Theiler's virus infection.

Authors:  Andrew J Steelman; Dana D Dean; Colin R Young; Roger Smith; Thomas W Prentice; Mary W Meagher; C Jane R Welsh
Journal:  Brain Behav Immun       Date:  2009-04-05       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.